摘要
目的:了解我院抗骨质疏松药的利用情况及应用趋势。方法:对我院2004年6月~2006年6月抗骨质疏松药销售金额、用药频度及日均费用等进行回顾性分析。结果:我院抗骨质疏松药中中成药仙灵骨葆和阿法骨化醇(阿法迪三)用药频度最高,双膦酸盐类增长迅速;日均费用以鲑降钙素(密盖息)最高。结论:以仙灵骨葆为主的中成药、骨吸收抑制剂及双膦酸盐在骨质疏松的治疗应用中呈上升趋势。
OBJECTIVE: To investigate the use and its tendency of anti- osteoporotics in our hospital.METHODS: The anti- osteoporotics used in Longhua hospital between June, 2004 and June, 2006 was analyzed in respect to consumption sum, DDDs and average daily expense etc.RESULTS: Xianlinggubao(a Chinese patent medicine) and alfacalcidol topped the list of anti -osteoporotics in terms of DDDs; the consumption of diphosphonates increased rapidly; miacalcic is the highest in average daily expense.CONCLUSION: The consumptions of Chinese patent medicine predominantly the Xianlinggubao, bone reabsorption inhibitors and diphosphonates showed an increasing tendency in the treatment of osteoporosis.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第26期2018-2019,共2页
China Pharmacy